Metformin as a Potential Neuroprotective Agent in Prodromal Parkinson's Disease—Viewpoint
To date, there are no clinically effective neuroprotective or disease-modifying treatments that can halt Parkinson's disease (PD) progression. The current clinical approach focuses on symptomatic management. This failure may relate to the complex neurobiology underpinning the development of PD and t...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Frontiers Media S.A.
2020-06-01
|
| Collection: | Frontiers in Neurology |
| Sujets: | |
| Accès en ligne: | https://www.frontiersin.org/article/10.3389/fneur.2020.00556/full |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|